We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Fate Of Calf Perforators After Endovenous Laser Ablation Of Saphenous Veins

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01458795
First Posted: October 25, 2011
Last Update Posted: November 3, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Ugur Ozkan, MD, Baskent University
  Purpose
The aim of this study is to evaluate the morphologic and hemodynamic changes in the calf perforators after endovenous laser ablation of saphenous veins.

Condition Intervention Phase
Venous Insufficiency Procedure: Endovenous laser ablation Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Official Title: The Fate Of Calf Perforators After Endovenous Laser Ablation Of Saphenous Veins

Further study details as provided by Ugur Ozkan, MD, Baskent University:

Estimated Enrollment: 60
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • Symptomatic patients who undergo EVLA procedure for saphenous vein insufficiency

Exclusion Criteria:

  • Patients with a history of deep venous thrombosis (DVT)
  • Previous varicose vein surgery or injection sclerotherapy
  • Patients without superficial venous incompetency
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01458795


Locations
Turkey
Baskent University
Adana, Turkey, 01250
Sponsors and Collaborators
Baskent University
  More Information

Responsible Party: Ugur Ozkan, MD, Associate professor of radiology, Baskent University
ClinicalTrials.gov Identifier: NCT01458795     History of Changes
Other Study ID Numbers: bask 012
First Submitted: October 20, 2011
First Posted: October 25, 2011
Last Update Posted: November 3, 2011
Last Verified: November 2011

Additional relevant MeSH terms:
Venous Insufficiency
Vascular Diseases
Cardiovascular Diseases